quality adjusted survival analysis
in controlled clinical trials, a type of survival analysis that not only predicts time to an event (e.g., number of years to death, time to relapse) but also recognizes aspects of the treatment that affect a patient’s quality of life. For example, the analysis would identify a treatment condition (e.g., introduction of a new drug) that might lead to longer but much lower quality of life for the patient.